In January of this year, the import and export volume of medicines and health products in China was 5.656 billion U.S. dollars, a year-on-year decrease of 4.26%, of which exports were 3.764 billion U.S. dollars, a slight increase of 0.54%, and imports were 1.888 billion U.S. dollars, down 12.58%. Spring and holiday factors are the main reasons for the sharp decline in the growth rate of imports and exports. At the same time, the European debt crisis and the slowdown in global economic growth have led to a slowdown in external demand. This is the biggest risk China's pharmaceutical exports are facing this year. The Spring Festival factor amplifies this. influences. The slowdown in import growth was mainly weighed down by the Chinese New Year holiday. At the same time, domestic economic growth has slowed down and demand growth has slowed down. It is expected that the import and export situation will improve rapidly in the future.